CLEAVE BIOSCIENCES INC has a total of 51 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ASLANIAN ROBERT G, AKADIA FARMAS JUTIKALZ INK and ENCYSIVE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Taiwan | 4 | |
#5 | China | 3 | |
#6 | Argentina | 2 | |
#7 | Australia | 2 | |
#8 | Canada | 2 | |
#9 | Chile | 2 | |
#10 | EAPO (Eurasian Patent Organization) | 2 | |
#11 | Israel | 2 | |
#12 | Mexico | 2 | |
#13 | New Zealand | 2 | |
#14 | South Africa | 2 | |
#15 | Brazil | 1 | |
#16 | Hong Kong | 1 | |
#17 | Hungary | 1 | |
#18 | Japan | 1 | |
#19 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Computer technology | |
#7 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Zhou Han-Jie | 40 |
#2 | Wustrow David | 36 |
#3 | Parlati Francesco | 19 |
#4 | Anderson Daniel | 3 |
#5 | David Wustrow | 3 |
#6 | Roufflet Matthieu | 2 |
#7 | Francesco Parlati | 2 |
#8 | Rice Julie | 2 |
#9 | Deshaies Raymond J | 2 |
#10 | Han-Jie Zhou | 2 |
Publication | Filing date | Title |
---|---|---|
US2017267679A1 | TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX | |
WO2016200840A1 | Mono and bicyclic ring boronic acid, ester and salt compounds as inhibitors of p97 complex | |
US2016355503A1 | NITROGEN HEXACYCLE COMPOUNDS AS INHIBITORS OF p97 COMPLEX | |
WO2016154110A1 | Companion diagnostic for p97 inhibitor therapy and methods of use thereof | |
WO2016007747A1 | Drug-resistant p97 atpase mutations | |
WO2015109285A1 | FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX | |
EP3080101A1 | Monocyclic pyrimidine/pyridine compounds as inhibitors of p97 complex | |
WO2014066506A2 | 8-thio quinazoline derivatives and 8-thio quinoline derivatives, pharmaceutical compositions thereof and methods for jamm protein inhibition | |
MX2015000908A | FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX. | |
WO2013123071A1 | Methods and compositions for jamm protease inhibition | |
EP2710119A1 | Compositions and methods for jamm protein inhibition |